DNA X, Inc. quarterly report, Q2 FY2022

Full document

Business context and reporting period

The supplied metadata names DNA X, Inc., but the filing identifies the registrant as Sonim Technologies, Inc. (Nasdaq: SONM). This unaudited Form 10-Q covers the quarter and six months ended June 30, 2022. Sonim sells rugged mobile phones and accessories, primarily through wireless carriers and other channel partners.

Financial performance and condition

Amounts below are in U.S. dollars; financial statement amounts are in thousands unless noted.

  • Revenue: Q2 revenue was $12.0 million, essentially unchanged year over year. First-half revenue increased 4% to $25.2 million. Smartphones grew in Q2 while feature-phone revenue declined. New products represented 48% of first-half units sold.
  • Profitability: Q2 gross profit rose 7% to $2.8 million, and gross margin was approximately 23.8%, compared with 22.2% a year earlier. First-half gross profit fell 15% to $4.4 million; gross margin was approximately 17.4%, versus 21.2%. Q2 net loss improved to $4.2 million from $6.7 million; first-half net loss improved to $11.4 million from $16.0 million. Basic and diluted loss per share was $0.22 for Q2 and $0.60 for the first half in 2022.
  • Expenses: Operating expenses declined 23% in Q2 to $7.1 million and 24% in the first half to $15.7 million. Lower R&D, general and administrative, and legal expenses contributed to the reductions. Operating losses were $4.2 million for Q2 and $11.3 million for the first half.
  • Cash flow and liquidity: Cash and equivalents were $18.2 million at June 30, versus $11.2 million at year-end 2021. First-half operating cash flow was positive $0.2 million, compared with cash used of $15.2 million in the prior-year period; working-capital movements, including receivables and inventory reductions, were significant contributors. Current assets were $31.2 million and current liabilities $27.9 million, including $6.8 million received for shares not yet issued at quarter-end.
  • Debt and leases: Long-term debt was $0.1 million, all current. Operating lease liabilities totaled $1.6 million following adoption of the lease accounting standard; $0.7 million was current. The company recorded a $1.0 million right-of-use asset impairment upon adoption.
  • Equity financing: Under an agreement with AJP Holding Company, Sonim received $17.5 million for 20.8 million shares at $0.84 per share in two post-quarter closings (July 13 and August 8, 2022). Approximately $3 million of transaction expenses were expected to reduce proceeds. AJP was expected to own approximately 52% of post-transaction shares.

Material changes versus the prior comparable period

  • Revenue was flat in Q2, while first-half revenue rose modestly, driven by new-product sales.
  • Q2 gross margin improved, but first-half gross profit and margin declined, partly reflecting scanner discounting as that product line was discontinued.
  • Operating losses narrowed in both periods, primarily as operating expenses decreased; legal expense was substantially lower in the first half than in 2021.
  • Cash increased, supported by the subscription-agreement proceeds and working-capital changes. The company’s share count and control structure changed materially after the quarter through the AJP transaction.

Outlook, risks, contingencies, and unusual items

  • Going concern: The financial-statement note says the quarterly loss raised substantial doubt about the company’s ability to continue as a going concern for at least one year. Management was evaluating additional funding alternatives and cautioned that financing might not be available on favorable terms or at all. The subsequent equity financing provided additional capital, but the filing’s risk-factor section also says the going-concern risk factor was no longer applicable after the $17.5 million raise; investors should note this differing presentation.
  • Products and demand: Management prioritized development of next-generation feature phones and a 5G smartphone, with introductions expected in the second half of 2022. Carrier design awards and purchase orders are not binding and may be terminated. Carrier certification requires time and investment, and management gave no formal financial guidance.
  • Concentration and commitments: The top five customers accounted for 79% of Q2 revenue and 81% of first-half revenue. One customer represented 51% of Q2 revenue. Noncancelable component purchase orders totaled $8.9 million; outsourced product-design commitments were $2.4 million.
  • Governance and listing: AJP’s investment brought a change in control, board composition, and senior management after quarter-end. The CFO and president resigned July 13 and became eligible for $1 million in severance over 20 months, subject to requirements. Sonim had received a Nasdaq minimum-bid-price deficiency notice and, on August 10, requested an additional compliance period; the outcome was not established in the filing.
  • Legal and controls: The SEC formal investigation remained ongoing, with its outcome and potential impact unknown. A prior federal securities class action settlement was paid and approved; a derivative action was dismissed with prejudice. Management concluded disclosure controls were not effective due to a material weakness involving IT access controls and a certification issue; remediation was expected in the second half of 2022.
  • Other unusual items: Sonim adopted lease accounting in 2022, limiting comparability with prior periods. It also reported a $912,000 customer receivable that was fully reserved; a July settlement yielded $91,000 cash and a write-off of the remainder against the reserve.

Important facts for investors to verify

  1. Confirm the issuer identity: the filing is for Sonim Technologies, Inc., not the company name in the request metadata.
  2. Review the AJP subscription agreement and subsequent share issuance, transaction costs, ownership, governance changes, and resulting dilution.
  3. Assess liquidity after the completed financing, the stated going-concern conclusion, and the difference between that disclosure and the risk-factor update.
  4. Monitor Nasdaq bid-price compliance and the status of the requested additional compliance period.
  5. Track customer concentration, nonbinding demand signals, product-launch and certification timing, and the company’s ability to fund product development.
  6. Follow remediation of the material weakness and developments in the SEC investigation.